Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 193,329 | 181,041 | 194,134 | 186,641 | 178,595 |
| Cost of Goods | 72,838 | 64,921 | 71,306 | 69,194 | 64,464 |
| Gross Profit | 120,491 | 116,120 | 122,828 | 117,447 | 114,131 |
| Operating Expenses | 113,329 | 96,169 | 98,971 | 90,332 | 90,016 |
| Operating Income | 8,000 | 20,872 | 24,163 | 27,309 | 24,579 |
| Interest Expense | 6,722 | 5,469 | 5,125 | 4,390 | 4,300 |
| Other Income | 720 | -570 | 402 | -648 | 815 |
| Pre-tax Income | 1,998 | 14,833 | 19,440 | 22,271 | 21,094 |
| Income Tax | 1,299 | 3,346 | 633 | 5,788 | 5,937 |
| Net Income Continuous | 699 | 11,487 | 18,807 | 16,483 | 15,157 |
| Net Income | $699 | $11,487 | $18,807 | $16,483 | $15,157 |
| EPS Basic Total Ops | 0.01 | 0.20 | 0.32 | 0.28 | 0.26 |
| EPS Basic Continuous Ops | 0.01 | 0.19 | 0.32 | 0.28 | 0.25 |
| EPS Diluted Total Ops | 0.01 | 0.19 | 0.31 | 0.28 | 0.25 |
| EPS Diluted Continuous Ops | 0.01 | 0.19 | 0.31 | 0.27 | 0.25 |
| EBITDA(a) | $23,814 | $31,347 | $35,092 | $37,414 | $34,419 |